跳至主要内容
临床试验/NCT06784479
NCT06784479进行中(未招募)4 期

A Randomized Clinical Trial to Evaluate the Sedative Effect of the Combination of Remimazolam and Propofol in Drug-induced Sleep Endoscopy

Dan Liu1 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2025年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
174
试验地点
1
主要终点
sedation success rate

研究概览

简要总结

This study helps patients find the optimal sedation regimen in drug-induced sleep endoscopy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients diagnosed with sleep apnea hypopnea syndrome were included

排除标准

  • •Patients were excluded if they had nasal obstruction, significantly deviated nasal septum, nasal turbinate hypertrophy, or nasal polyps. Patients with uncontrolled heart failure, renal insufficiency, diabetes, or hyperthyroidism were also excluded. Patients were also excluded if taking medications that could affect upper airway muscle function, such as ben- zodiazepines and muscle relaxants.

研究组 & 干预措施

Application of remimazolam and propofol to achieve satisfactory sedative effect

Experimental

干预措施: Remimazolam and Propofol (Drug)

Application of propofol to achieve satisfactory sedative effect

Active Comparator

干预措施: Propofol (Drug)

Application of midazolam and propofol to achieve satisfactory sedative effect

Active Comparator

干预措施: Midazolam and propofol (Drug)

结局指标

主要结局

sedation success rate

时间窗: During procedure (From the start of drug induced sleep endoscopy to the complete awakening of the patient)

a composite measure including completion of the DISE, no requirement for rescue sedative medication, and no requirement for more than 5 top-up doses of the trial medication after the initial dose.

次要结局

  • Procedure-related adverse effect-The need for antidote administration(During procedure (From the start of drug induced sleep endoscopy to the complete awakening of the patient))
  • Procedure-related adverse effect-The occurrence of tachycardia(During procedure (From the start of drug induced sleep endoscopy to the complete awakening of the patient))
  • Procedure-related adverse effect-The occurrence of hypotension(During procedure (From the start of drug induced sleep endoscopy to the complete awakening of the patient))
  • Procedure-related adverse effect-The occurrence of hypoxemia(During procedure (From the start of drug induced sleep endoscopy to the complete awakening of the patient))
  • The degree of patient and physician satisfaction(During procedure (the start of drug induced sleep endoscopy to the complete awakening of the patient))
  • Sedative effect-Adequate sedation time(During procedure (From the start of medication to target BIS range), an average of 2min)
  • Sedative effect-sedation to recovery time(The time period of the end of operation to complete wakefulness,through operation completion, an average of 30min)

研究者

发起方
Dan Liu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dan Liu

Master of Medicine, attending physician

Tianjin Medical University General Hospital

研究点 (1)

Loading locations...

相似试验